Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Introduction: Oncologists have traditionally administered the maximum tolerated doses of drugs in chemotherapy. However, these toxicity-guided doses may lead to suboptimal efficacy. CURATE.AI is an indication-agnostic, mechanism-independent and efficacy-driven personalised dosing platform that may o...

Full description

Bibliographic Details
Main Authors: Benjamin Kye Jyn Tan, Chong Boon Teo, Xavier Tadeo, Siyu Peng, Hazel Pei Lin Soh, Sherry De Xuan Du, Vilianty Wen Ya Luo, Aishwarya Bandla, Raghav Sundar, Dean Ho, Theodore Wonpeum Kee, Agata Blasiak
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Digital Health
Subjects:
clinical decision support system
chemotherapy
personalised medicine
clinical trials
artificial intelligence
oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fdgth.2021.635524/full

Internet

https://www.frontiersin.org/articles/10.3389/fdgth.2021.635524/full

Similar Items